Dr. Sandy Srinivas
Stanford University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Dr. Sandy Srinivas as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:31 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT01450683 · Study of Itraconazole in Castrate-resistant Prostate Cancer (CRPC) Post-chemotherapyStanford University · terminated · Prostate Cancer, Prostatic Neoplasms, Castrate-resistant Prostate Cancer (CRPC) · principal investigator
- Ph1NCT01155791 · Phase I Sodium Selenite in Combination With Docetaxel in Castration-resistant Prostate CancerSandy Srinivas · terminated · Urologic Neoplasms, Prostate Cancer, Prostate Cancer Metastatic Disease · principal investigator
- Ph2NCT01108055 · Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial CancerSandy Srinivas · completed · Bladder Cancer, Bladder (Urothelial, Transitional Cell) Cancer, Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive) · principal investigator
- Ph2NCT00854620 · Safety and Toxicity Study of Sorafenib in Patients With Kidney CancerStanford University · completed · Carcinoma, Renal Cell, Kidney Disease, Kidney Cancer · principal investigator
- Ph2NCT00651482 · Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RAD001 (Everolimus)Sandy Srinivas · terminated · Kidney Neoplasms, Kidney (Renal Cell) Cancer · principal investigator
- Ph2NCT00476645 · Fulvestrant in Hormone Refractory Prostate CancerStanford University · completed · Prostatic Neoplasms, Prostate Cancer · principal investigator
- Ph2NCT00477087 · Phase II GM-CSF Plus Mitoxantrone in Hormone Refractory Prostate CancerStanford University · terminated · Prostatic Neoplasms · principal investigator
- Ph2NCT00383487 · A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate CancerStanford University · terminated · Prostatic Neoplasms, Prostate Cancer · principal investigator
- Ph2NCT00226954 · Zoledronic Acid With Intermittent Hormonal Therapy in Patients With Prostate CancerStanford University · terminated · Urologic Neoplasms · principal investigator
- Ph2NCT00226980 · A Trial of Thalidomide and Capecitabine in Metastatic Renal Cell CarcinomaStanford University · completed · Kidney Neoplasms · principal investigator
- Ph2NCT00186277 · Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder CancerStanford University · completed · Bladder Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:31 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 3 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.